Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.61 |
| ▸ | CTSS | P25774 | 5/20 | 0.55 |
| ▸ | CTSL | P07711 | 4/20 | 0.55 |
| ▸ | MME | P08473 | 2/20 | 0.54 |
| ▸ | ECE1 | P42892 | 2/20 | 0.54 |
| ▸ | CTSK | P43235 | 5/20 | 0.53 |
| ▸ | CTSB | P07858 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8496964 | 1.00 | SMN1; SMN2 (0.61) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| Hydroxyamine SCHEMBL9197242 | 0.99 | SMN1; SMN2 (0.60) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| SCHEMBL9228661 | 0.98 | SMN1; SMN2 (0.59) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| SCHEMBL9228658 | 0.98 | SMN1; SMN2 (0.59) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| SCHEMBL29437121 | 0.94 | SMN1; SMN2 (0.62) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| SCHEMBL1122463 | 0.91 | CTSS (0.58) | CTSSCTSLMMEECE1CTSK | |
| SCHEMBL13884485 | 0.91 | CTSS (0.58) | CTSSCTSLMMEECE1CTSK | |
| SCHEMBL14433709 | 0.91 | CTSS (0.58) | CTSSCTSLMMEECE1CTSK | |
| SCHEMBL10385461 | 0.90 | SMN1; SMN2 (0.60) | SMN1; SMN2CTSSCTSLMMEECE1 | |
| SCHEMBL10385459 | 0.90 | SMN1; SMN2 (0.60) | SMN1; SMN2CTSSCTSLMMEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 607 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117165149-B | Epoxy zinc-rich primer containing graphene-conductive nickel material and preparation method thereof | 成都虹润制漆有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-117165149-A | Epoxy zinc-rich primer containing graphene-conductive nickel material and preparation method thereof | 成都虹润制漆有限公司 | 2023-12-05 | — | — | CN | claimed |
| CN-114634966-A | Enzyme activity detection method of protein glutamyl enzyme and application thereof | 武汉新华扬生物股份有限公司 | 2022-06-17 | — | — | CN | claimed |
| EP-0379606-B2 | Novel transglutaminase | AJINOMOTO KK (JP) | 1999-07-28 | — | — | EP | claimed |
| EP-0555046-B1 | Method for determination of calcium | ORIENTAL YEAST CO LTD (JP) | 1997-07-30 | — | — | EP | claimed |
| US-5618684-A | CALCIUM ACTIVATED TRANSGLUTAMINASE ACTS ON SUBSTRATE TO GENERATE AMMONIA; CORRELATING AMOUNT OF AMMONIA GENERATED WITH AN AMOUNT OF CALCIUM | ORIENTAL YEAST CO., LTD. (JP) | 1997-04-08 | — | — | US | claimed |
| JP-7075569-A | — | — | None | — | — | JP | disclosed |
| US-20260137106-A1 | PROCESS FOR PREPARING A LIQUID OAT BASE | OATLY AB (SE) | 2026-05-21 | — | — | US | disclosed |
| US-20260139068-A1 | ANTI-CD73 ANTIBODIES, CONJUGATES, AND METHODS OF USE | EISAI R&D MAN CO LTD (JP) | 2026-05-21 | — | — | US | disclosed |
| US-12630807-B2 | Modified transglutaminase | AMANO ENZYME INC. (JP) | 2026-05-19 | — | — | US | disclosed |
| EP-4739141-A1 | METHOD FOR OBTAINING A DAIRY ALTERNATIVE FOOD PRODUCT WITH IMPROVED FOAMING | Novozymes A/S (DK) | 2026-05-13 | — | — | EP | disclosed |
| US-12616231-B2 | Heat coagulation gel strength regulating agent for egg white protein | AMANO ENZYME INC. (JP) | 2026-05-05 | — | — | US | disclosed |
| EP-4729611-A1 | LIQUID ENZYME PREPARATION | Amano Enzyme Inc. (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-5252469-A | Culturing the microorganism in the absence of calcium ion | AMANO PHARMACEUTICAL CO., LTD. (JP) | 1993-10-12 | — | — | US | disclosed |
| EP-0555046-A1 | Method for determination of calcium | ORIENTAL YEAST CO., LTD. (JP) | 1993-08-11 | — | — | EP | disclosed |
| US-5156956-A | Derived from microorganism; catalyzes protein gelation in absence of calcium | AJINOMOTO CO., INC. (JP) | 1992-10-20 | — | — | US | disclosed |
| US-5055310-A | Reacting soy milk with solidifying agent and transglutaminase enzyme as catalyst | AJINOMOTO CO., INC. (JP) | 1991-10-08 | — | — | US | disclosed |
| US-4970297-A | CONTAINING ISOXAZOLE RING | SYNTEX (U.S.A.) INC. (US) | 1990-11-13 | — | — | US | disclosed |
| EP-0379606-A1 | Novel transglutaminase | AJINOMOTO CO., INC. (JP) | 1990-08-01 | — | — | EP | disclosed |
| JP-H00775569-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139068-A1 | ANTI-CD73 ANTIBODIES, CONJUGATES, AND METHODS OF USE | ENTPD3, ENTPD1, ENTPD2 | SMN1; SMN2 3883/4885CTSS 3758/4885CTSL 4056/4885 |
| US-12616231-B2 | Heat coagulation gel strength regulating agent for egg white protein | TGM2, TGM3, TGM1 | SMN1; SMN2 4192/4885CTSS 881/4885CTSL 1131/4885 |
| US-20260137106-A1 | PROCESS FOR PREPARING A LIQUID OAT BASE | GYS1, OAT, GYS2 | SMN1; SMN2 3472/4885CTSS 114/4885CTSL 104/4885 |
| US-12630807-B2 | Modified transglutaminase | TGM2, GLUL, TGM1 | SMN1; SMN2 2866/4885CTSS 2090/4885CTSL 1798/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.